DH

David Hagerty

BS Bristol-Myers Squibb: 9 patents #582 of 3,969Top 15%
📍 Encinitas, CA: #261 of 1,440 inventorsTop 20%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #568,767 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
10052360 Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule Robert E. Cohen, Suzette Belder-Carr, Robert James Peach, Jean-Claude Becker 2018-08-21
9296808 Methods for treating scleroderma by administering a soluble CTLA4 molecule Robert E. Cohen, Suzette Belder-Carr, Robert James Peach, Jean-Claude Becker 2016-03-29
8722632 Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule Robert E. Cohen, Suzette Belder-Carr, Robert James Peach, Jean-Claude Becker 2014-05-13
8703718 Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule Robert E. Cohen, Suzette Belder-Carr, Robert James Peach, Jean-Claude Becker 2014-04-22
8497247 Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule Robert E. Cohen, Suzette Carr, Robert James Peach, Jean-Claude Becker 2013-07-30
8227420 Method for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID Robert E. Cohen, Suzette Carr, Robert James Peach, Jean-Claude Becker 2012-07-24
8148332 Method for treating a rheumatic disease using a soluble TLA4 molecule Robert E. Cohen, Suzette Carr, Robert James Peach, Jean-Claude Becker 2012-04-03
7482327 Methods for treating immune disorders associated with graft transplantation with soluble CTLA4 mutant molecules James Rusnak 2009-01-27
7455835 Methods for treating immune system diseases using a soluble CTLA4 molecule Robert E. Cohen, Robert James Peach, Suzette Carr, Jean-Claude Becker, Peter S. Linsley +2 more 2008-11-25